Accessibility settings

JMIR Cancer

Patient-centered innovations, education, and technology for cancer care, cancer survivorship, and cancer research.

Editor-in-Chief:

Matthew Balcarras, MSc, PhD, Scientific Editor at JMIR Publications, Ontario, Canada


Impact Factor 2.7 More information about Impact Factor CiteScore 4.1 More information about CiteScore

JMIR Cancer is a peer-reviewed journal focusing on education, innovation and technology in cancer care, cancer survivorship and cancer research, and participatory and patient-centred approaches. This journal also includes research on non-Internet approaches to improve cancer care and cancer research.

We invite submissions of original research, viewpoints, reviews, tutorials, and non-conventional articles (e.g. open patient education material and software resources that are not yet evaluated but are free for others to use/implement). 

In our "Patients' Corner," we invite patients and survivors to submit short essays and viewpoints on all aspects of cancer. In particular, we are interested in suggestions on improving the health care system and suggestions for new technologies, applications and approaches (this section has no article processing fees).

JMIR Cancer is indexed in PubMed Central and PubMedScopusDOAJ, MEDLINE, and the Emerging Sources Citation Index (Clarivate)

JMIR Cancer received a 2025 Impact Factor of 2.6, ranking Q3 in Oncology (196/333).

JMIR Cancer received a Scopus CiteScore of 4.1 (2025), placing it in the 50th percentile (213/428) as a second quartile (Q2) journal in the field of Oncology.

Recent Articles

Patient on video call with doctor, discussing telehealth services
Cancer Survivorship

As the number of cancer survivors continues to grow, optimizing long-term survivorship care models has become increasingly important. Telehealth has the potential to improve access to health care for survivors; however, studies evaluating telehealth in this population remain limited. Additionally, concerns persist regarding equity in technology access and digital literacy.

Nurse explains X-ray to elderly patient in hospital bed
Clinical Cancer Research

With the rapid development of medical technology and the emphasis on early lung cancer screening, the detection rate of multiple primary lung cancer (MPLC) has increased in recent years. However, the prognostic determinants and clinical characteristics of patients with MPLC remain poorly characterized.

Doctors review patient data on a tablet, discussing medical information.
Patient Education for Cancer

Effective communication about breast and cervical cancers remains a public health challenge, with widespread misinformation and barriers to cancer-related language understanding. Large language models (LLMs) offer potential for scalable health communication, yet trade-offs between quality, safety, and accessibility of general-purpose and medical-domain LLMs remain underexplored.

Person using smartphone while taking notes on a notebook.
Mobile Apps for Cancer Care and Cancer Prevention and Screening

Digital health interventions are increasingly being integrated into oncological care to support patients in managing treatment-related symptoms and psychological distress. In a randomized controlled pilot trial, we investigated the feasibility and preliminary efficacy of a digital health app (SOFIA) among patients with cancer, including those in palliative care. SOFIA consists of an electronic patient-reported outcome (ePRO) assessment and coaching component. We showed good feasibility and high acceptability of SOFIA in routine clinical care.

Computer screen displaying lungs icon and "CHECK" button for lung health check.
Patient Education for Cancer

Lung cancer remains the leading cause of cancer deaths in the United States; however, uptake of lung cancer screening (LCS) with low-dose computed tomography (LDCT) among eligible individuals remains low. Evidence suggests that limited knowledge, stigma, and false health beliefs contribute to the underuse of LDCT screening.

3D illustration of prostate exam with ultrasound probe and world map
Prostate Cancer

Focal high-intensity focused ultrasound (HIFU) is an emerging tissue-preserving treatment for localized prostate cancer (PCa) that aims to reduce functional impairment and psychological burden while maintaining oncological safety. Although its clinical use is increasing, prospective data on health-related quality of life (HRQoL) and psychological distress after focal hemiablation remain limited.

Elderly woman using smartphone with smart home health dashboard overlay
Emotional, Social, Psychological Support for Cancer

Older survivors of cancer face heightened risk of depression and anxiety related to cancer experiences, fear of recurrence, and aging-related difficulties. Conventional mental health monitoring approaches, such as clinical assessments and even electronic patient-reported outcomes, are limited by recall bias, patient burden, and infrequent data collection. Emerging patient-generated health data from wearables and smart home devices offer passive, low-burden, continuous monitoring, but their ability to capture mental health risks in older survivors of cancer remains unclear.

Doctor reassures patient with cancer, shaking hands and smiling
Breast Cancer

Breast cancer is the most common cancer among Canadian women, bringing complex demands for timely decision-making, coordination of multidisciplinary care, and efficient communication between patients and providers. The increasing reliance on fragmented and noninteroperable health information systems exacerbates workflow and documentation burdens, leading to inefficiencies and gaps in continuity of care. While nurse navigation programs partially bridge these gaps, most digital platforms remain poorly integrated into provider workflows, requiring manual tracking, which results in duplicated effort and reduced efficiency. Our team developed “MyJourney” at North York General Hospital (NYGH) in Ontario. It is a digital navigation platform that supports breast cancer care throughout the entire continuum, from diagnosis to survivorship.

Child's hand wearing a pink smartwatch, touching the screen.
Patient Education for Cancer

Consumer smartwatches offer potential for continuous monitoring of physical activity during childhood cancer treatment. However, their validity for measuring step count and heart rate in this population has not been established.

Elderly Asian woman in conversation with a healthcare professional.
Reviews on Innovations in Cancer

Endocrine therapy is a fundamental treatment for hormone receptor–positive breast cancer. However, treatment-related symptoms may lead to poor adherence and premature discontinuation, adversely affecting clinical outcomes. eHealth technology interventions have been widely applied as potential tools to support patient education, symptom management, and adherence.

Teenage boy sitting on a bed, looking at his smartphone.
HPV Vaccination

Despite the human papillomavirus (HPV) vaccine being available to males for the past 12 years, adolescent males continue to lag in HPV vaccine uptake due to a variety of factors. With the ubiquitous nature of social media use among this population, further research is needed to improve HPV vaccine confidence among young adolescent males using these platforms.

Person using smartphone with glowing medical icons, representing digital health technology
Questionnaires and Research Instruments for Cancer Patients

With increasing numbers of survivors with cancer, the importance of patient-centered information provision and communication to alleviate psychological burdens, such as anxiety and depression, is growing. However, substantial individual differences exist in patients with cancer information–seeking behaviors and use of support services, and few studies have comprehensively examined cognitive and psychological factors such as treatment status, sex, trust in information sources, and patient-provider relationships.

Preprints Open for Peer Review

We are working in partnership with